Biotechnology - , Washington, United States
Algomedix is an emerging biotechnology company focused on the discovery and development of novel therapeutics to treat pain, inflammation, ocular and dermatological disease. The novel small molecules target members of the TRP family, and thus are non-opioid, non-NSAID, and are designed to have no addiction or abuse liabilities. These advantages are further enhanced by having a peripheral mechanism of action, blocking pain at its source. Algomedix possesses near-term clinical development opportunities combined with novel approaches to developing its first-in-class novel therapeutics addressing a critical unmet medical need.Algomedix's most advanced patented compound is in late-stage preclinical development. This compound has demonstrated potent analgesic activity activity in multiple established pain models which are appropriate for multiple therapeutic applications. In addition, Algomedix is pursuing programs developing a pipeline of novel, first-in-class molecules for other indications, which include chronic kidney disease and cardiac hypertrophy
Nginx
WordPress.org
Google Cloud Hosting
Bootstrap Framework
Mobile Friendly